Increased understanding of the Skp2 gene and its relation to cellular senescence may lead to the development of novel agents that can suppress tumor development in common types of cancer ...

Article Reference: Shi-Bing Zhang, Ming Hong and Xiao-Yang Sun et al. Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2. Acta Materia Medica. Vol. 1(3 ...

Pfizer, Arvinas post mixed breast cancer survival results in first phase 3 test for a PROTAC degrader. By James Waldron Mar 11, 2025 10:06am. Pfizer Arvinas breast cancer PROTAC. Pfizer and ...